Ledger.Open graph →
SEC Form D · filed March 22, 2012

Tarsa Therapeutics, Inc

Offering
$28.0M
Sold
$13.8M
Exemption
—
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

People & firms on this filing (13)

Eric Bednarski · Boston, MADirectorLewis Geffen · Boston, MAExecGregory Lumpkin · Philadelphia, PAExecDavid Brand · Boston, MAExec · DirectorMartin Edwards · Philadelphia, PADirectorEric Bednarski · Waltham, MADirectorLewis Geffen · BOSTON, MAExecAshleigh Palmer · Philadelphia, PADirectorGregory Lumpkin · Philadelphia, PAExecDavid Brand · Philadelphia, PAExec · DirectorJames Tananbaum · Fort Washington, PADirectorMartin Edwards · Philadelphia, PADirectorMatthew Rieke · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗